Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Aerie Pharmaceuticals Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
AERI
Nasdaq
2834
http://www.aeriepharma.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Aerie Pharmaceuticals Inc
Aerie Pharmaceuticals to Participate in the Jefferies Healthcare Conference on Friday, June 10, 2022 at 10:30 a.m. ET
- May 25th, 2022 8:30 pm
Aerie (AERI) Starts Late-Stage Study to Treat Dry Eye Disease
- May 25th, 2022 6:29 pm
Aerie Pharmaceuticals Announces First Participant Dosed in the Phase 3 Registrational COMET-2 Study of AR-15512 for the Treatment of Dry Eye Disease
- May 24th, 2022 11:30 am
Further weakness as Aerie Pharmaceuticals (NASDAQ:AERI) drops 12% this week, taking three-year losses to 85%
- May 7th, 2022 1:28 pm
Aerie (AERI) Q1 Loss Wider Than Expected, Revenues Rise Y/Y
- May 6th, 2022 7:48 pm
Aerie Pharmaceuticals (AERI) Reports Q1 Loss, Misses Revenue Estimates
- May 5th, 2022 9:55 pm
Aerie Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update
- May 5th, 2022 8:01 pm
Aerie Pharmaceuticals to Announce First Quarter 2022 Financial Results and Host Conference Call on Thursday, May 5, 2022 at 5:00 p.m. ET
- Apr 28th, 2022 8:35 pm
Aerie Pharmaceuticals Announces Presentations at the Association for Research in Vision and Ophthalmology Annual Meeting in Denver, Colorado, May 1-4, 2022
- Apr 26th, 2022 8:05 pm
Aerie Pharmaceuticals Announces Presentations at the American Society of Cataract and Refractive Surgery (ASCRS 2022) in Washington, D.C., April 22-26, 2022
- Apr 20th, 2022 8:05 pm
Aerie (AERI) Expands Market Presence Despite Stiff Competition
- Apr 11th, 2022 6:54 pm
Aerie Pharmaceuticals to Participate in the 21st Annual Needham Virtual Healthcare Conference on Tuesday, April 12, 2022 at 3:00 p.m. ET
- Apr 6th, 2022 8:30 pm
Aerie Pharmaceuticals Appoints Peter Lang as Chief Financial Officer
- Mar 18th, 2022 11:00 am
Top Pharmaceutical Stocks for Q2 2022
- Mar 17th, 2022 2:45 pm
Aerie (AERI) Q4 Earnings Beat Estimates, Revenues Up Y/Y
- Feb 25th, 2022 3:14 pm
Aerie Pharmaceuticals (AERI) Tops Q4 Earnings and Revenue Estimates
- Feb 24th, 2022 11:00 pm
Aerie Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
- Feb 24th, 2022 9:01 pm
Aerie Pharmaceuticals Appoints Gary Sternberg, M.D., M.B.A. as Chief Medical Officer
- Feb 24th, 2022 11:30 am
Drug/Biotech Stocks' Q4 Earnings on Feb 24: MRNA, EBS & More
- Feb 23rd, 2022 4:44 pm
Aerie Pharmaceuticals to Announce Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call on Thursday, February 24, 2022 at 5:00 p.m. ET
- Feb 17th, 2022 9:45 pm
Scroll